Knowledge andStructure-Based Drug Design of 15-PGDHInhibitors
Leela S. Dodda(Nimbus (Italy)), Neelu Kaila, David Ciccone(Harvard University), Fu‐Shan Kuo(Ensemble Therapeutics (United States)), Sébastien Campos(Pharmaron (United Kingdom)), Scott D. Edmondson(Unknown), Md Munan Shaik(Boston Children's Hospital), Suzanne Jacques-O’Hagan(Ensemble Therapeutics (United States)), Peter J. Tummino(Intarcia Therapeutics (United States)), Samantha Carreiro(Ensemble Therapeutics (United States)), Debra Brennan, Silvana Leit, Daniel Price(Nimbus (Italy)), Sheetal Kumar(Addenbrooke's Hospital), Jacqueto Zephyr(Nimbus (Italy)), Christine Loh
Cited by 0
Related Papers
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
LigParGen web server: an automatic OPLS-AA parameter generator for organic ligands
|Nucleic Acids Research|2017|1.6k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function
|Biochemistry|2008|550